Two Sigma Advisers’s Cellectar Biosciences CLRB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-447
| Closed | -$53.3K | – | 2476 |
|
|
2024
Q1 | $53.3K | Buy |
+447
| New | +$53.3K | ﹤0.01% | 2348 |
|
|
2022
Q2 | – | Sell |
-36
| Closed | -$7K | – | 2687 |
|
|
2022
Q1 | $7K | Sell |
36
-355
| -91% | -$69K | ﹤0.01% | 2704 |
|
|
2021
Q4 | $78K | Buy |
391
+192
| +96% | +$38.3K | ﹤0.01% | 2436 |
|
|
2021
Q3 | $55K | Sell |
199
-970
| -83% | -$268K | ﹤0.01% | 2365 |
|
|
2021
Q2 | $417K | Sell |
1,169
-980
| -46% | -$350K | ﹤0.01% | 2022 |
|
|
2021
Q1 | $1.04M | Buy |
+2,149
| New | +$1.04M | ﹤0.01% | 1635 |
|
|
2020
Q3 | – | Sell |
-184
| Closed | -$71K | – | 2429 |
|
|
2020
Q2 | $71K | Buy |
+184
| New | +$71K | ﹤0.01% | 2401 |
|